At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BIAF bioAffinity Technologies, Inc.
Trading 02-25 13:42:32 EST
1.07
-0.04
-3.60%
High1.10
Low1.04
Vol62.60K
Open1.09
D1 Closing1.11
Amplitude5.40%
Mkt Cap4.81M
Tradable Cap3.64M
Total Shares4.50M
T/O66.62K
T/O Rate1.84%
Tradable Shares3.40M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
BRIEF-Bioaffinity Announces Validation Study For Lung Cancer Test
bioAffinity Technologies Announces Validation Study With Brooke Army Medical Center to Expand SAMPLE Collection Options for the Cypath® Lung Noninvasive Early Detection Lung Cancer Test
Wallachbeth Capital Announces the Closing of bioAffinity Technologies $1.8M Registered Direct Financing of Common Stock Priced at-the-Market Under Nasdaq Rules
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung. It offers CyPath lung, a diagnostic test, for early detection of lung cancer. The company was incorporated in 2014 and is based in San Antonio, Texas.